Migraine Briefs

Migraine with Aura Linked with TIA Readmission

Headache; ePub 2018 Jun 22; Velickovic Ostojic, et al


 

In a large, nationally representative retrospective cohort study, migraine admission with aura was independently associated with transient ischemic attack (TIA) readmission, and status migrainosus was independently associated with subarachnoid hemorrhage. The Nationwide Readmissions Database was designed to analyze readmissions for all payers and uninsured, with data on more than 14 million US admissions in 2013. Researchers identified index migraine admissions with and without aura or status migrainosus, and readmissions for cerebrovascular events. Cox proportional hazards regression was performed for each outcome with aura and status migrainosus as main predictors, adjusting for age and vascular risk factors. They found:

  • Out of 12,448 index admissions for migraine, 9972 (80.1%) were women, mean age was 45.5 ± 14.8 years, aura was present in 3038 (24.41%), and status migrainosus in 1798 (14.44%).
  • The 30‐day readmission rate (per 100,000 index admissions) was 154 for ischemic stroke, 86 for TIA, 42 for subarachnoid hemorrhage, and 17 for intracranial hemorrhage.
  • In unadjusted models, aura was significantly associated with TIA (hazard ratio 2.43), but not acute ischemic stroke (1.26), intracranial hemorrhage (1.86), or subarachnoid hemorrhage (1.85).

Velickovic Osotjic L, Liang JW, Sheikh HU, Dhamoon MS. Impact of aura and status migrainosus on readmissions for vascular events after migraine admission. [Published online ahead of print June 22, 2018]. Headache. doi:10.1111/head.13347.

Recommended Reading

How Common Are Comorbidities in Chronic Versus Episodic Migraine?
Migraine ICYMI
Ubrogepant May Treat Acute Migraine Attacks Effectively
Migraine ICYMI
Quantitative Sensory Testing in Those with Migraine
Migraine ICYMI
Migraineurs’ Initiation of Behavioral Treatment
Migraine ICYMI
Migraineurs Have Reduced Visual Quality of Life
Migraine ICYMI
Cognitive Behavioral Therapy for Pediatric Migraine
Migraine ICYMI
Eptinezumab May Reduce Migraine Frequency in Patients With Chronic and Episodic Migraine
Migraine ICYMI
Fremanezumab May Be an Effective Preventive Treatment for Chronic Migraine
Migraine ICYMI
Migraine, Post-Surgery Pain, and Re-hospitalization
Migraine ICYMI
Headache/Migraine Apps Sharing Information
Migraine ICYMI